ACHIEVE LIFE SCIENCES INC. - COMMON SHARES

Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program

13 May 2025 07:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025

06 May 2025 08:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine

21 Apr 2025 11:19:48 By Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program

11 Mar 2025 07:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference

07 Mar 2025 08:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025

06 Mar 2025 08:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference

11 Feb 2025 08:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial

10 Feb 2025 08:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors

10 Jan 2025 08:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission

07 Jan 2025 08:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week

06 Jan 2025 08:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

09 Dec 2024 08:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA

03 Dec 2024 08:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

14 Nov 2024 08:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update

07 Nov 2024 16:05:01 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024

24 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting

23 Oct 2024 08:00:01 By Nasdaq GlobeNewswire

Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline

16 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting

10 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs

01 Oct 2024 08:46:16 By Nasdaq GlobeNewswire